Ying Choi Yu
Chief Executive Officer chez CK LIFE SCIENCES INT'L., (HOLDINGS) INC.
Fortune : 96 300 $ au 31/03/2024
Profil
Ying Choi Yu is currently the CEO, Executive Director, VP & Compliance Officer at CK Life Sciences International (Holdings), Inc. and a Member at The Hong Kong Institute of Directors.
Previously, Mr. Yu served as the Chairman at WEX Pharmaceuticals, Inc. and as the Vice President-Worldwide at Johnson & Johnson (Hong Kong) Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 2 250 000 ( 0,02% ) | 96 300 $ | 31/03/2024 |
Postes actifs de Ying Choi Yu
| Sociétés | Poste | Début |
|---|---|---|
| CK LIFE SCIENCES INT'L., (HOLDINGS) INC. | Chief Executive Officer | 01/09/2020 |
The Hong Kong Institute of Directors
 The Hong Kong Institute of Directors Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Directors operates as premier body which represents professional directors. The company was founded by Moses Cheng in 1997 and is headquartered in Hong Kong. | Corporate Officer/Principal | - |
Anciens postes connus de Ying Choi Yu
| Sociétés | Poste | Fin |
|---|---|---|
Johnson & Johnson (Hong Kong) Ltd.
 Johnson & Johnson (Hong Kong) Ltd. Household/Personal CareConsumer Non-Durables Johnson & Johnson (Hong Kong) Ltd. provides healthcare products and solutions. It operates through the following business segments: Consumer, Pharmaceuticals, and Medical devices. The Consumer segment includes baby care products, beauty products, wound care products, oral care products, and over-the-counter healthcare products. The Pharmaceuticals segment provides healthcare services related to immunology, cardiovascular and metabolic diseases, pulmonary hypertension, infectious diseases and vaccines, neuroscience, and oncology. The Medical devices segment includes endomechanical, biosurgery, wound closure, sterilization, orthopedics, and diabetes care products. The company was founded on December 3, 1971 and is headquartered in Hong Kong. | Corporate Officer/Principal | - |
WEX Pharmaceuticals, Inc.
 WEX Pharmaceuticals, Inc. Medical DistributorsDistribution Services WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada. | Chairman | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CK LIFE SCIENCES INT'L., (HOLDINGS) INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
WEX Pharmaceuticals, Inc.
WEX Pharmaceuticals, Inc. Medical DistributorsDistribution Services WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada. | Distribution Services |
The Hong Kong Institute of Directors
The Hong Kong Institute of Directors Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Directors operates as premier body which represents professional directors. The company was founded by Moses Cheng in 1997 and is headquartered in Hong Kong. | Commercial Services |
Johnson & Johnson (Hong Kong) Ltd.
Johnson & Johnson (Hong Kong) Ltd. Household/Personal CareConsumer Non-Durables Johnson & Johnson (Hong Kong) Ltd. provides healthcare products and solutions. It operates through the following business segments: Consumer, Pharmaceuticals, and Medical devices. The Consumer segment includes baby care products, beauty products, wound care products, oral care products, and over-the-counter healthcare products. The Pharmaceuticals segment provides healthcare services related to immunology, cardiovascular and metabolic diseases, pulmonary hypertension, infectious diseases and vaccines, neuroscience, and oncology. The Medical devices segment includes endomechanical, biosurgery, wound closure, sterilization, orthopedics, and diabetes care products. The company was founded on December 3, 1971 and is headquartered in Hong Kong. | Consumer Non-Durables |
